PURA - Puration Previews EVERx CBD Infused Water Product Launch Plans Set For Major Industry Trade Show In March 2017
January 12 2017 - 8:30AM
InvestorsHub NewsWire
Dallas, TX – January 12, 2017 – Puration, Inc.
(USOTC:
PURA) today announced plans for the official launch its EVERx
Cannabinoil (CBD) Infused Water at a major industry trade show in
March 2017. Working with Alkame Holdings’
(USOTC: ALKM) wholly owned subsidiary Xtreme
Technologies, PURA has developed the EVERx CBD Infused
Sports Drink with 10 mg of CBD in a 16.9 oz bottle. PURA
will release the trade show details in early February. The
trade show launch will be combined with the announcement of a
notable sports figure spokesman for the EVERx brand. Based on
an existing EVERx pre-order and the first distribution agreement,
PURA anticipates $1 million in EVERx sales in
2017. PURA has published a comprehensive $3
million first year revenue plan for its overall product
line.
PURA Proprietary CBD Extract and ALKM Water
Technology
PURA’s proprietary CBD extract process is combined
with ALKM’s patented technology that alters the
structure of water, producing a combination of characteristics that
are unprecedented in the beverage industry. The
ALKM technology breaks down the hydrogen bonds,
reducing water's cluster size, providing a more efficient delivery
system for the CBD. Separate from the infused CBD, the
ALKM technology includes an optimal alkaline pH
level formulated with antioxidants and electrolytes for effective
hydration.
EVERx CBD Infused Water Target
Market
EVERx will target the growing number of recreational and
competitive athletes citing CBD for its benefits in
substantially reducing recovery times and increasing cardio output
as well as accelerating the healing process from injury and
preventing against future injury. EVERx will also target the
general consumer that is becoming more aware of
the antioxidant and neural- protective research backed
benefits of CBD. Research has shown CBD to mitigate
diabetes risk and reduce cancer cells among demonstrating
other specific targeted uses.
CBD for Fitness and
Wellness
CBD is an ideal component of a pre
and post workout regime. CBD works as an anti-inflammatory
and relieves muscle spasms. CBD also works to relieve
pain. CBD protects the heart, lungs and brain. Often
essential when it comes to high intensity and competitive training,
CBD reduces nausea, increases appetite and aides sleep.
Ongoing research continues in regard to CBD as a treatment for
sports related head trauma. CBD is not just a good addition
to an athletes training regime; It can be the foundation of a
healthy wellness routine for everyone.
CBD Water and the North
American Cannabis Holdings (USMJ) EVERx Brand
PURA’s
EVERx CBD Infused Water is one of an
overall line of planned products under the EVERx brand name.
The EVERx brand is owned by PURA’s partner North American Cannabis
Holdings, Inc. (USOTC: USMJ). Last
year, USMJ introduced the EVERx Sports and Fitness Nutritional Supplement Brand
Name. PURA has entered into an
agreement with USMJ to develop, market and sell a
CBD Infused Water in a campaign designed to complement
USMJ’s comprehensive EVERx brand.
$279.65 Billion Bottled Water
Market
The bottled water market was valued
at US $157.27 billion in 2013 and is expected to reach US $279.65
billion by 2020 (Transparency
Market Research). Given
the magnitude of the bottled water market, management plans to
review first quarter performance and potentially increase the first
year target at that time.
To learn more about North American Cannabis
Holdings: growusmj.com.
Follow the Company on Twitter:
US_HEMP
To learn more about
Puration:
purationinc.com
Follow Puration on Twitter:
Puration710
Visit Puration on
Facebook:
Facebook.com/puration/
To learn more about Alamke Holdings, Inc.:
alkameholdingsinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies’ contracts, the companies’ liquidity position, the
companies’ ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure or prevent any disease.
Puration Contact:
Brian Shibley, CEO
[email protected]
+1-214-937-9097
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024